Literature DB >> 30102773

Measuring blood velocity using 4D-DSA: A feasibility study.

Gabe Shaughnessy1, Sebastian Schafer2, Michael A Speidel1, Charles M Strother3, Charles A Mistretta1.   

Abstract

PURPOSE: Four-dimensional (4D) DSA reconstruction provides three-dimensional (3D) time-resolved visualization of contrast bolus passage through arterial vasculature in the interventional setting. The purpose of this study was to evaluate the feasibility of using these data in measuring blood velocity and flow.
METHODS: The pulsatile signals in the time concentration curves (TCCs) measured at different points along a vessel are markers of the movement of a contrast bolus and thus of blood flow. When combined with the spatial content, that is, geometry of the vasculature, this information then provides the data required to determine blood velocity. A Fourier-based algorithm was used to identify and follow the pulsatility signal. A Side Band Ratio (SBR) metric was used to reduce uncertainty in identifying the pulsatility in regions where the signal was weak. We tested this method using 4D-DSA reconstructions from vascular phantoms as well as from human studies.
RESULTS: In five studies using 3D printed patient-specific cerebrovascular phantoms, velocities calculated from the 4D-DSAs were found to be within 10% of velocities measured with a flow meter. Calculated velocity and flow values from three human studies were within the range of those reported in the literature.
CONCLUSIONS: 4D-DSA provides temporal and spatial information about blood flow and vascular geometry. This information is obtained using conventional rotational angiographic systems. In this small feasibility study, these data allowed calculations of velocity values that correlated well with measured values. The availability of velocity and blood flow information in the interventional setting would support a more quantitative approach to diagnosis, treatment planning and post-treatment evaluations of a variety of cerebrovascular diseases.
© 2018 American Association of Physicists in Medicine.

Entities:  

Keywords:  4D-DSA; blood flow; blood velocimetry

Mesh:

Year:  2018        PMID: 30102773      PMCID: PMC6767933          DOI: 10.1002/mp.13120

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  6 in total

1.  Optimizing the Quality of 4D-DSA Temporal Information.

Authors:  K L Ruedinger; E C Harvey; S Schafer; M A Speidel; C M Strother
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-31       Impact factor: 3.825

2.  Initial investigation of the use of angiographic parametric imaging for early prognosis of delayed cerebral ischemia in patients with subarachnoid hemorrhage.

Authors:  Roman D Price; Mohammad Mahdi Shiraz Bhurwani; Kelsey N Sommer; Andrei Monteiro; Ammad A Baig; Jason M Davies; Adnan H Siddiqui; Ciprian N Ionita
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2022-04-04

Review 3.  4D-DSA: Development and Current Neurovascular Applications.

Authors:  K L Ruedinger; S Schafer; M A Speidel; C M Strother
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-26       Impact factor: 3.825

4.  Virtual 2D angiography from four-dimensional digital subtraction angiography (4D-DSA): A feasibility study.

Authors:  Jay F Yu; Leland Pung; Hataka Minami; Kerstin Mueller; Rajkamal Khangura; Robert Darflinger; Steven W Hetts; Daniel L Cooke
Journal:  Interv Neuroradiol       Date:  2020-09-26       Impact factor: 1.610

5.  Optimization of quantitative time-resolved 3D (4D) digital subtraction angiography in a porcine liver model.

Authors:  Ece Meram; Gabe Shaughnessy; Colin Longhurst; Carson Hoffman; Martin Wagner; Charles A Mistretta; Michael A Speidel; Paul F Laeseke
Journal:  Eur Radiol Exp       Date:  2020-07-02

6.  A technique for intra-procedural blood velocity quantitation using time-resolved 2D digital subtraction angiography.

Authors:  Carson Hoffman; Sarvesh Periyasamy; Colin Longhurst; Rafael Medero; Alejandro Roldan-Alzate; Michael A Speidel; Paul F Laeseke
Journal:  CVIR Endovasc       Date:  2021-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.